The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRIT Capital Partners Regulatory News (RCP)

Share Price Information for RIT Capital Partners (RCP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,000.00
Bid: 2,005.00
Ask: 2,010.00
Change: -10.00 (-0.50%)
Spread: 5.00 (0.249%)
Open: 2,000.00
High: 2,025.00
Low: 1,998.00
Prev. Close: 2,010.00
RCP Live PriceLast checked at -
RIT Capital Partners is an Investment Trust

To invest in a widely diversified, international portfolio across a range of asset classes, both quoted and unquoted; to allocate part of the portfolio to exceptional managers in order to ensure access to the best external talent available.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Net Asset Value(s)

16 Oct 2023 07:00

RNS Number : 1276Q
RIT Capital Partners PLC
16 October 2023

RIT Capital Partners PLC (LEI: P31Q1NLTW35JJGHA4667)

16 October 2023

30 September 2023 Net Asset Value

The unaudited diluted net asset value (NAV) of RIT Capital Partners plc as at 30 September 2023 (with debt at fair value) was 2,409p per £1 ordinary share (31 August 2023: 2,399p).

September 2023 Highlights

In September, global equities had the largest monthly decline so far in 2023, as bond yields widened on the back of expectations of higher-for-longer interest rates as signalled by central banks. The US S&P 500 led the declines at -4.8% for the month, while fears of the impact of rates on Eurozone GDP led to a decline in the Stoxx Europe 600 of -1.6%. Continued concerns over the health of the domestic real estate market left the China CSI 300 down -2.0%. In the UK, slowing inflation and the Bank of England's decision to hold interest rates steady resulted in sterling falling by -3.7% against the US dollar.

Against this backdrop, our portfolio showed resilience and ended the month in positive territory. Our moderate net equity exposure, our meaningful US dollar position and healthy performance from certain direct stock positions within the Quoted Equities book helped contribute to NAV performance amidst the challenging market environment.

· Our Quoted Equities book detracted during the month, with the decrease mainly driven by life sciences and Chinese holdings. This was partly offset by strength from our Japanese holdings, and gains in the share prices of certain value stock positions.

· Private Investments were flat for the month. During September, we continued to receive further valuation marks to 30 June from our private funds book, with the net contribution from new marks received being roughly flat. As of 30 September, ~93% of our private fund positions (up from ~80% as of 31 August) were held at 30 June reported valuations and ~6% were held at 31 March. All private direct positions are valued as at 30 June.

· Our Uncorrelated Strategies book was also steady in September. During the month, we saw positive contributions from credit strategies as well as our macro manager holdings, with gold detracting.

· The Board continued its active buyback programme, generating a further accretive impact to the NAV per share. In the month of September, the Company repurchased approximately 0.5 million shares on behalf of shareholders.

For more information:

J. Rothschild Capital Management (Investment Manager):

T: 020 7647 8565

E: investorrelations@ritcap.co.uk

Numis (Joint Broker):

David Benda

T: 020 7260 1000

JP Morgan Cazenove (Joint Broker):

William Simmonds

T: 020 3493 8000

Brunswick Group LLP (Media enquiries):

Nick Cosgrove, Tom Burns

T: 020 7404 5959

E: RIT@BrunswickGroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NAVEXLFFXBLLFBK
Date   Source Headline
2nd May 20246:18 pmRNSResult of AGM
1st May 202412:00 pmRNSTotal Voting Rights
1st May 20247:00 amRNSTransaction in Own Shares
30th Apr 20247:00 amRNSTransaction in Own Shares
30th Apr 20247:00 amRNSDirector/PDMR Shareholding
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSNet Asset Value(s)
4th Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20242:27 pmRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
20th Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20245:22 pmRNSDirector/PDMR Shareholding
18th Mar 20247:00 amRNSNet Asset Value(s)
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20244:56 pmRNSDirector/PDMR Shareholding
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:00 amRNSFinal Results
5th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 202410:32 amRNSTotal Voting Rights
1st Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20245:13 pmRNSDirectorate Change
29th Feb 20247:00 amRNSTransaction in Own Shares
28th Feb 20247:00 amRNSTransaction in Own Shares
27th Feb 20247:00 amRNSTransaction in Own Shares
26th Feb 20241:31 pmRNSCompany Announcement
26th Feb 20247:00 amRNSTransaction in Own Shares
23rd Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 20247:00 amRNSTransaction in Own Shares
21st Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 20247:00 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSNet Asset Value(s)
19th Feb 20247:00 amRNSTransaction in Own Shares
16th Feb 20247:00 amRNSTransaction in Own Shares
15th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 20247:00 amRNSTransaction in Own Shares
13th Feb 20247:00 amRNSTransaction in Own Shares
9th Feb 20247:00 amRNSTransaction in Own Shares
8th Feb 20247:00 amRNSTransaction in Own Shares
7th Feb 20247:00 amRNSNet Asset Value(s)
7th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.